299 related articles for article (PubMed ID: 12718032)
21. Epstein-Barr virus-associated lymphomas.
Gandhi MK
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):77-89. PubMed ID: 16441211
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic application of Epstein-Barr virus-encoded RNA in situ hybridisation.
Loughrey M; Trivett M; Lade S; Murray W; Turner H; Waring P
Pathology; 2004 Aug; 36(4):301-8. PubMed ID: 15370127
[TBL] [Abstract][Full Text] [Related]
23. Virology. Epstein-Barr virus turns 50.
Lieberman PM
Science; 2014 Mar; 343(6177):1323-5. PubMed ID: 24653027
[No Abstract] [Full Text] [Related]
24. Epstein-Barr virus--associated diseases in humans.
Kawa K
Int J Hematol; 2000 Feb; 71(2):108-17. PubMed ID: 10745621
[TBL] [Abstract][Full Text] [Related]
25. Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus?
Starkebaum G
J Rheumatol; 2001 Dec; 28(12):2573-5. PubMed ID: 11764198
[No Abstract] [Full Text] [Related]
26. [Oncogenic mechanisms of Epstein-Barr virus].
Herrero JA
Enferm Infecc Microbiol Clin; 1996 Nov; 14(9):551-60. PubMed ID: 9035714
[No Abstract] [Full Text] [Related]
27. The Epstein-Barr virus: historical, biologic, pathologic and oncologic considerations.
Seemayer TA; Oligny LL; Gartner JG
Perspect Pediatr Pathol; 1981; 6():1-33. PubMed ID: 6275338
[No Abstract] [Full Text] [Related]
28. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
Kimura H
Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated lymphoproliferative disorders.
Ambinder RF
Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
[TBL] [Abstract][Full Text] [Related]
30. The promise of a prophylactic Epstein-Barr virus vaccine.
Balfour HH; Schmeling DO; Grimm-Geris JM
Pediatr Res; 2020 Jan; 87(2):345-352. PubMed ID: 31641280
[TBL] [Abstract][Full Text] [Related]
31. [Epstein-Barr virus infections. New pathogenic and clinical aspects].
Wilmes E; Wolf H
Laryngorhinootologie; 1989 Jan; 68(1):36-43. PubMed ID: 2536874
[TBL] [Abstract][Full Text] [Related]
32. [Biology of the Epstein-Barr virus].
Morand P; Seigneurin JM
Ann Biol Clin (Paris); 1989; 47(7):421-7. PubMed ID: 2554764
[TBL] [Abstract][Full Text] [Related]
33. Vaccine Development for Epstein-Barr Virus.
Cohen JI
Adv Exp Med Biol; 2018; 1045():477-493. PubMed ID: 29896681
[TBL] [Abstract][Full Text] [Related]
34. Reactivation of Epstein-Barr virus from latency.
Amon W; Farrell PJ
Rev Med Virol; 2005; 15(3):149-56. PubMed ID: 15546128
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.
Shah KM; Young LS
Clin Microbiol Infect; 2009 Nov; 15(11):982-8. PubMed ID: 19874382
[TBL] [Abstract][Full Text] [Related]
36. [Epstein-Barr virus infection and its related diseases].
Zhao LQ; Qian Y
Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):797-9. PubMed ID: 14731376
[No Abstract] [Full Text] [Related]
37. Epstein-Barr virus in human disease.
Langenhuysen MM; The TH
Neth J Med; 1973; 16(2):85-93. PubMed ID: 4350284
[No Abstract] [Full Text] [Related]
38. Association of Epstein-Barr virus with human neoplasia.
Gaffey MJ; Weiss LM
Pathol Annu; 1992; 27 Pt 1():55-74. PubMed ID: 1310536
[No Abstract] [Full Text] [Related]
39. Viral DNA Loads in Various Blood Components of Patients With Epstein-Barr Virus-Positive T-Cell/Natural Killer Cell Lymphoproliferative Diseases.
Kawada JI; Kamiya Y; Sawada A; Iwatsuki K; Izutsu K; Torii Y; Kimura H; Ito Y
J Infect Dis; 2019 Sep; 220(8):1307-1311. PubMed ID: 31240305
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.
Hui KF; Tam KP; Chiang AKS
Viruses; 2017 Nov; 9(11):. PubMed ID: 29160853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
